Loading…
Drug-drug interactions in subjects enrolled in SWOG trials of oral chemotherapy
Marcath, Lauren A., Finley, Colin M., Wong, Siu Fun, Hertz, Daniel L.
Published in BMC cancer (26.03.2021)
Published in BMC cancer (26.03.2021)
Get full text
Journal Article
Loading…
Efficacy and safety of T-DM1 in the ‘common-practice’ of HER2+ advanced breast cancer setting: a multicenter study
Fabi, Alessandra, De Laurentiis, Michelino, Caruso, Michele, Valle, Enrichetta, Moscetti, Luca, Santini, Daniele, Cannita, Katia, Carbognin, Luisa, Ciccarese, Mariangela, Rossello, Rosalba, Arpino, Grazia, Leonardi, Vita, Montemurro, Filippo, La Verde, Nicla, Generali, Daniele, Zambelli, Alberto, Scandurra, Giuseppa, Russillo, Michelangelo, Paris, Ida, D'Ottavio, Anna Maria, Filippelli, Gianfranco, Giampaglia, Marianna, Stani, Simonetta, Fabbri, Agnese, Alesini, Daniele, Cianniello, Daniela, Giannarelli, Diana, Cognetti, Francesco
Published in Oncotarget (08.09.2017)
Published in Oncotarget (08.09.2017)
Get full text
Journal Article
Loading…
Linking MedDRA®-Coded Clinical Phenotypes to Biological Mechanisms by the Ontology of Adverse Events: A Pilot Study on Tyrosine Kinase Inhibitors
Sarntivijai, Sirarat, Zhang, Shelley, Jagannathan, Desikan G., Zaman, Shadia, Burkhart, Keith K., Omenn, Gilbert S., He, Yongqun, Athey, Brian D., Abernethy, Darrell R.
Published in Drug safety (01.07.2016)
Published in Drug safety (01.07.2016)
Get full text
Journal Article
Loading…
Loading…
Chemotherapy and targeted therapy for breast cancer patients with hepatitis C virus infection
Talima, Soha, Kassem, Hebatallah, Kassem, Neemat
Published in Breast cancer (Tokyo, Japan) (01.03.2019)
Published in Breast cancer (Tokyo, Japan) (01.03.2019)
Get full text
Journal Article
Loading…
Establishment of a trastuzumab-resistant extramammary Paget disease model: loss of PTEN as a potential mechanism
Hsu, Che-Yuan, Yanagi, Teruki, Maeda, Takuya, Nishihara, Hiroshi, Funakoshi, Takeru, Miyamoto, Kodai, Iwamoto, Ririko, Takahashi, Kenzo, Ujiie, Hideyuki
Published in British journal of cancer (21.09.2024)
Published in British journal of cancer (21.09.2024)
Get full text
Journal Article
Loading…
Breast Cancer Resistance Protein (ABCG2) in Clinical Pharmacokinetics and Drug Interactions: Practical Recommendations for Clinical Victim and Perpetrator Drug-Drug Interaction Study Design
Lee, Caroline A, O’Connor, Meeghan A, Ritchie, Tasha K, Galetin, Aleksandra, Cook, Jack A, Ragueneau-Majlessi, Isabelle, Ellens, Harma, Feng, Bo, Taub, Mitchell E, Paine, Mary F, Polli, Joseph W, Ware, Joseph A, Zamek-Gliszczynski, Maciej J
Published in Drug metabolism and disposition (01.04.2015)
Published in Drug metabolism and disposition (01.04.2015)
Get full text
Journal Article
Loading…
Computational and Functional Analyses of HER2 Mutations Reveal Allosteric Activation Mechanisms and Altered Pharmacologic Effects
Ishiyama, Noboru, O'Connor, Matthew, Salomatov, Andrei, Romashko, Darlene, Thakur, Shalabh, Mentes, Ahmet, Hopkins, Julia F., Frampton, Garrett M., Albacker, Lee A., Kohlmann, Anna, Roberts, Christopher, Buck, Elizabeth
Published in Cancer research (Chicago, Ill.) (02.05.2023)
Published in Cancer research (Chicago, Ill.) (02.05.2023)
Get full text
Journal Article
Loading…
Abstract OT1-07-04: [Fam-] trastuzumab deruxtecan (T-DXd; DS-8201a) vs investigator’s choice of treatment in subjects with HER2-positive, unresectable and/or metastatic breast cancer who previously received T-DM1: A randomized, phase 3 trial (DESTINY-Breast02)
André, Fabrice, Shahidi, Javad, Lee, Caleb, Wang, Kongming, Krop, Ian E
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Published in Cancer research (Chicago, Ill.) (15.02.2020)
Get full text
Journal Article
Loading…
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
Giuliano, Mario, Giordano, Antonio, Jackson, Summer, Hess, Kenneth R, De Giorgi, Ugo, Mego, Michal, Handy, Beverly C, Ueno, Naoto T, Alvarez, Ricardo H, De Laurentiis, Michelino, De Placido, Sabino, Valero, Vicente, Hortobagyi, Gabriel N, Reuben, James M, Cristofanilli, Massimo
Published in Breast cancer research : BCR (15.06.2011)
Published in Breast cancer research : BCR (15.06.2011)
Get full text
Journal Article
Loading…
Abstract C041: Safety and pharmacokinetic results from a phase 1, multicenter, open-label study of [fam-] trastuzumab deruxtecan (T-DXd; DS-8201a) in subjects with advanced HER2-positive breast cancer
Chang, Dwan-Ying, Lin, Chia-Chi, Chen, Tom Wei-Wu, Lin, Ching-Hung, Lee, Jih-Hsiang, Chao, Ta-Chung, Liu, Chun-Yu, Achiwa, Issei, Kamiyama, Emi, Okuda, Yasuyuki, Lee, Caleb, Chao, Yee
Published in Molecular cancer therapeutics (01.12.2019)
Published in Molecular cancer therapeutics (01.12.2019)
Get full text
Journal Article
Loading…
Loading…
Abstract OT2-07-02: Trastuzumab deruxtecan (DS-8201a) vs investigator's choice of treatment in subjects with HER2-positive, unresectable and/or metastatic breast cancer who previously received T-DM1: A randomized, phase 3 study
André, F, Shahidi, J, Lee, C, Wang, K, Krop, IE
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
Loading…
Inhibition of paracetamol glucuronidation by tyrosine kinase inhibitors
Liu, Yong, Ramírez, Jacqueline, Ratain, Mark J.
Published in British journal of clinical pharmacology (01.06.2011)
Published in British journal of clinical pharmacology (01.06.2011)
Get full text
Journal Article
Loading…
Loading…
Loading…
Loading…
Efficacy and Safety of Pyrotinib Versus T-DM1 in HER2+ Metastatic Breast Cancer Patients Pre-Treated With Trastuzumab and a Taxane: A Bayesian Network Meta-Analysis
Liao, Hao, Huang, Wenfa, Liu, Yaxin, Pei, Wendi, Li, Huiping
Published in Frontiers in oncology (03.05.2021)
Published in Frontiers in oncology (03.05.2021)
Get full text
Journal Article
Loading…
Lysosomotropic-related limitations of the BALB/c 3T3 cell-based neutral red uptake assay and an alternative testing approach for assessing e-liquid cytotoxicity
Cudazzo, Gianluca, Smart, Daniel J., McHugh, Damian, Vanscheeuwijck, Patrick
Published in Toxicology in vitro (01.12.2019)
Published in Toxicology in vitro (01.12.2019)
Get full text
Journal Article
Loading…
Phase 1 dose-escalation study of S-222611, an oral reversible dual tyrosine kinase inhibitor of EGFR and HER2, in patients with solid tumours
Spicer, J., Baird, R., Suder, A., Cresti, N., Corbacho, J. Garcia, Hogarth, L., Frenkel, E., Matsumoto, S., Kawabata, I., Donaldson, K., Posner, J., Sarker, D., Jodrell, D., Plummer, R.
Published in European journal of cancer (1990) (01.01.2015)
Published in European journal of cancer (1990) (01.01.2015)
Get full text
Journal Article